Interpace Biosciences, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2014 | $95.8M | $115.2M | $23.1M |
| FY2015 | $54.7M | $64.7M | $8.3M |
| FY2016 | $35.2M | $25.1M | $602.0K |
| FY2017 | $13.7M | $36.6M | $15.2M |
| FY2018 | $15.7M | $31.1M | $6.1M |
| FY2019 | $29.8M | $51.5M | $2.3M |
| FY2020 | $28.2M | $45.7M | $2.8M |
| FY2021 | $34.3M | $38.4M | $2.7M |
| FY2022 | $32.5M | $16.0M | $4.8M |
| FY2023 | $26.8M | $16.0M | $5.6M |